Amoxicillin; Omeprazole Magnesium; Rifabutin Patent Expiration

Amoxicillin; Omeprazole Magnesium; Rifabutin is Used for treating Helicobacter pylori infection in adults. It was first introduced by Redhill Biopharma Ltd in its drug Talicia on Nov 1, 2019.


Amoxicillin; Omeprazole Magnesium; Rifabutin Patents

Given below is the list of patents protecting Amoxicillin; Omeprazole Magnesium; Rifabutin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Talicia US10238606 Pharmaceutical compositions for the treatment of Helicobacter pylori Feb 12, 2034 Redhill
Talicia US11135172 Rifabutin-based compositions and methods for treating Helicobacter pylori infection Feb 12, 2034 Redhill
Talicia US11878011 Method for eradicating Helicobacter pylori infection in patients regardless of body mass index May 27, 2042 Redhill
Talicia US11931463 All-in-one fixed-dose combination for treating Helicobacter pylori infection Feb 12, 2034 Redhill
Talicia US9050263 Pharmaceutical compositions for the treatment of Helicobacter pylori Feb 12, 2034 Redhill
Talicia US9498445 Pharmaceutical compositions for the treatment of Helicobacter pylori Feb 12, 2034 Redhill
Talicia US9603806 Pharmaceutical compositions for the treatment of Helicobacter pylori Feb 12, 2034 Redhill


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Amoxicillin; Omeprazole Magnesium; Rifabutin's patents.

Given below is the list recent legal activities going on the following patents of Amoxicillin; Omeprazole Magnesium; Rifabutin.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 08 May, 2024 US9498445
Recordation of Patent eGrant 19 Mar, 2024 US11931463
Recordation of Patent Grant Mailed 19 Mar, 2024 US11931463
Email Notification 19 Mar, 2024 US11931463
Mail Patent eGrant Notification 19 Mar, 2024 US11931463
Patent eGrant Notification 19 Mar, 2024 US11931463
Patent Issue Date Used in PTA Calculation 19 Mar, 2024 US11931463
Email Notification 29 Feb, 2024 US11931463
Issue Notification Mailed 28 Feb, 2024 US11931463
Application Is Considered Ready for Issue 09 Feb, 2024 US11931463



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳